Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Endo

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Calcified Tissue International|June 19, 2017
Eldecalcitol, an Active Vitamin D<sub>3</sub> Derivative, Prevents Trabecular Bone Loss and Bone Fragility in Type I Diabetic Model RatsSatoshi Takeda, Mitsuru Saito, Sadaoki Sakai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic actionMichinori Hirata, Koichi Endo, Kyoko Katsumata, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2003
In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3Michinori Hirata, Kyoko Katsumata, Koichi Endo, et al.
European Journal of Pharmacology|October 4, 2015
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Pharmacology|August 24, 2020
Prolonged Duration of Erythropoiesis-Stimulating Agents' Action Delays Disease Progression in Anti-Thy 1 Antibody-Induced Chronic Glomerulonephritis RatsRyohei Kawasaki, Yoshihito Tashiro, Kenji Yogo, et al.
Journal of the American Medical Directors Association|May 15, 2026
Participation in Community Gathering Places and Subsequent Care Costs in Older Adults: A 2-Year Follow-Up StudyKazuki Uemura, Yuta Kuroda, Katsura Matsunami, et al.
Cardiovascular Therapeutics|January 6, 2017
Epoetin beta pegol ameliorates flow-mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
The Journal of Endocrinology|November 6, 2015
Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Nihon Arukoru Yakubutsu Igakkai Zasshi = Japanese Journal of Alcohol Studies & Drug Dependence|August 25, 2011
[Effectiveness of drinking plan and drinking diary in intervention program (HAPPY program) for heavy drinkers]Toshiya Hara, Takeo Muto, Chikako Yoshimori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic ratsMichinori Hirata, Koichi Endo, Hiroyuki Ohkawa, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Calcified Tissue International|June 19, 2017
Eldecalcitol, an Active Vitamin D<sub>3</sub> Derivative, Prevents Trabecular Bone Loss and Bone Fragility in Type I Diabetic Model RatsSatoshi Takeda, Mitsuru Saito, Sadaoki Sakai, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
A comparison between 1,25-dihydroxy-22-oxavitamin D(3) and 1,25-dihydroxyvitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic actionMichinori Hirata, Koichi Endo, Kyoko Katsumata, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2003
In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3Michinori Hirata, Kyoko Katsumata, Koichi Endo, et al.
European Journal of Pharmacology|October 4, 2015
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Pharmacology|August 24, 2020
Prolonged Duration of Erythropoiesis-Stimulating Agents' Action Delays Disease Progression in Anti-Thy 1 Antibody-Induced Chronic Glomerulonephritis RatsRyohei Kawasaki, Yoshihito Tashiro, Kenji Yogo, et al.
Journal of the American Medical Directors Association|May 15, 2026
Participation in Community Gathering Places and Subsequent Care Costs in Older Adults: A 2-Year Follow-Up StudyKazuki Uemura, Yuta Kuroda, Katsura Matsunami, et al.
Cardiovascular Therapeutics|January 6, 2017
Epoetin beta pegol ameliorates flow-mediated dilation with improving endothelial nitric oxide synthase coupling state in nonobese diabetic ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
The Journal of Endocrinology|November 6, 2015
Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model ratsKenichi Serizawa, Kenji Yogo, Yoshihito Tashiro, et al.
Nihon Arukoru Yakubutsu Igakkai Zasshi = Japanese Journal of Alcohol Studies & Drug Dependence|August 25, 2011
[Effectiveness of drinking plan and drinking diary in intervention program (HAPPY program) for heavy drinkers]Toshiya Hara, Takeo Muto, Chikako Yoshimori, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
A comparison between daily and thrice-weekly i.v. administration of 1,25-dihydroxy-22-oxavitamin D(3) regarding suppression of parathyroid hormone secretion and calcaemic action in uraemic ratsMichinori Hirata, Koichi Endo, Hiroyuki Ohkawa, et al.
Pageof 4